ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. A SINGLE PILOT ANTICOAGULATION RISK MANAGEMENT CENTER

被引：0
|
作者：
Varga, A. [1 ]
Tatar, C. M. [2 ]
Mitre, A. [3 ]
Podoleanu, C. [4 ]
Tilea, I. [1 ]
机构：
[1] Univ Med & Pharm, Fac Med, Dept M3, Family Med, Targu Mures, Romania
[2] Univ Med & Pharm, Fac Med, Dept M3, Internal Med 3, Targu Mures, Romania
[3] Univ Med & Pharm, Fac Med, Dept M3, Internal Med 6, Targu Mures, Romania
[4] Univ Med & Pharm, Fac Med, Dept M3, Internal Med 4, Targu Mures, Romania
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000491388.49360.7c
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
OP2C:05
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [21] Individual risk prediction of anticoagulation in atrial fibrillation patients with cirrhosis
    Kim, I.
    Lee, H. W.
    Kim, B. K.
    Seo, J. W.
    Min, P. K.
    Choi, E. Y.
    Yoon, Y. W.
    Lee, B. K.
    Hong, B. K.
    Rim, S. J.
    Kwon, H. M.
    Kim, J. Y.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [22] The prevalence and correlative factors of atrial fibrillation in hypertensive patients: a single-center retrospective study
    Liu, Qian
    Zhang, Pengqiang
    Chen, Liang
    Sun, Jingyi
    Ding, Yanchun
    Yang, Donghui
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C151 - C151
  • [23] Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients. the life study
    Bang, C. N.
    Okin, P.
    Gottlieb, A. B.
    Kober, L.
    Wachtell, K.
    Devereux, R. B.
    EUROPEAN HEART JOURNAL, 2013, 34 : 916 - 916
  • [24] Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
    Law, Mandy M.
    Tan, Sven-Jean
    Wong, Michael C. G.
    Toussaint, Nigel D.
    KIDNEY MEDICINE, 2023, 5 (09)
  • [25] The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US
    Patrick W. Sullivan
    Thomas W. Arant
    Samuel L. Ellis
    Heather Ulrich
    PharmacoEconomics, 2006, 24 : 1021 - 1033
  • [26] Anticoagulation management in non-valvular atrial fibrillation in rural and remote areas: a single-center study
    Papakonstantinou, P.
    Asimakopoulou, N.
    Gargeraki, A.
    Mintzaridis, E.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1349 - 1350
  • [27] The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US
    Sullivan, Patrick W.
    Arant, Thomas W.
    Ellis, Samuel L.
    Ulrich, Heather
    PHARMACOECONOMICS, 2006, 24 (10) : 1021 - 1033
  • [28] Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial
    Harel, Ziv
    Smyth, Brendan
    Badve, Sunil V.
    Blum, Daniel
    Beaubien-Souligny, William
    Silver, Samuel A.
    Clark, Edward
    Suri, Rita
    Mavrakanas, Thomas A.
    Sasal, Joanna
    Prasad, Bhanu
    Eikelboom, John
    Tennankore, Karthik
    Rigatto, Claudio
    Prce, Ivana
    Madore, Francois
    Mac-Way, Fabrice
    Steele, Andrew
    Zeng, Yangmin
    Sholzberg, Michelle
    Dorian, Paul
    Yan, Andrew T.
    Sood, Manish M.
    Gladstone, David J.
    Tseng, Eric
    Kitchlu, Abhijat
    Walsh, Michael
    Sapir, Danny
    Oliver, Matthew J.
    Krishnan, Murali
    Kiaii, Mercedeh
    Wong, Nikki
    Kotwal, Sradha
    Battistella, Marisa
    Acedillo, Rey
    Lok, Charmaine
    Weir, Matthew
    Wald, Ron
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [29] Utility of current stroke risk schemes in patients with atrial fibrillation: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Fang, MC
    Go, AS
    Chang, YC
    Henault, LE
    Jensvold, NJ
    Singer, DE
    CIRCULATION, 2006, 113 (08) : E302 - E302
  • [30] Anticoagulation in patients with nonvalvular atrial fibrillation
    Bosomworth, N. John
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (06) : 381 - 381
12345